Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2014)

View and export this data going back to 2007. Start your Free Trial

What is Omni Bio Pharmaceutical 3-Year EBITDA Growth Rate?

Omni Bio Pharmaceutical's EBITDA per Share for the three months ended in Dec. 2014 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate falls into.

Omni Bio Pharmaceutical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Omni Bio Pharmaceutical (GREY:OMBP) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Omni Bio Pharmaceutical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omni Bio Pharmaceutical Inc (GREY:OMBP) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

5350 South Roslyn, Suite 430, Greenwood Village, CO, USA, 80111

Website

http://www.omnibiopharma.com

Omni Bio Pharmaceutical Inc is a US-based biopharmaceutical company, which is engaged in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. Further, it focuses on the research and development efforts of advancing its first recombinant molecule, AAT and an Fc component of immunoglobulin (AAT-Fc 2) into clinical trials. Geographically these activities are functioned through the region of US.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Headlines

No Headlines